{"id":"amixetrine","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["amixetrine hydrochloride","amixetrine"],"offLabel":[],"synonyms":["amixetrine hydrochloride","amixetrine"],"timeline":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body's cells are like locks, and proteins or receptors are like keys. AMIXETRINE is like a key that fits into a specific lock, allowing it to turn and unlock a cellular process that helps to treat a particular disease or condition. This process can help to restore balance and normal function to the body's cells and tissues.","oneSentence":"AMIXETRINE works by binding to specific proteins or receptors in the body to produce a therapeutic effect.","technicalDetail":"AMIXETRINE is a small molecule that likely interacts with its target through non-covalent binding, potentially altering the target's conformation or activity to produce a therapeutic effect."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3672","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=AMIXETRINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T08:42:18.908775","biosimilars":[],"competitors":[],"genericName":"amixetrine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"7UL287YTPJ","CHEBI":"CHEBI:135077","INN_ID":"3170","UMLSCUI":"C0051695","ChEMBL_ID":"CHEMBL2104080","PUBCHEM_CID":"71911","SECONDARY_CAS_RN":"24622-52-4","MESH_SUPPLEMENTAL_RECORD_UI":"C012181"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":3,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"AMIXETRINE","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"AMIXETRINE is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it has not been approved by the FDA for any indications. As a small molecule, it is likely to work by interacting with specific biological molecules to produce a therapeutic effect. However, without more information, it is difficult to provide a comprehensive summary of its mechanism of action and safety considerations. Further research is needed to fully understand this drug's properties and potential uses.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}